Valion Bio, Inc. Other Nonoperating Expense
Valion Bio, Inc. (VBIO) reported Other Nonoperating Expense of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2024-11-14
- Valion Bio, Inc. other nonoperating expense for the quarter ending 2024-09-30 was $0.00.
- Valion Bio, Inc. other nonoperating expense for the quarter ending 2024-06-30 was $60.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $60.00K derived: sum of 2 quarters · filed 2024-11-14 | $60.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $60.00K 10-Q · filed 2024-08-14 | $60.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |